Table of Content

Table of Contents

Global Age Related Macular Degeneration Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Lucentis -Product Introduction and Major Manufacturers
1.1.2 Eylea -Product Introduction and Major Manufacturers
1.1.3 Avastin -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.1.1 China Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.2.1 EU Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.3.1 USA Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.4.1 Japan Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.5.1 India Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.7.1 South America Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.8.1 Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.8.2 Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Age Related Macular Degeneration Drug Market Assessment by Segment
3.1 Global Age Related Macular Degeneration Drug Capacity and Growth Rate
3.2 Global Age Related Macular Degeneration Drug Sales by Type
3.3 Global Age Related Macular Degeneration Drug Sales Revenue by Type
3.4 Global Age Related Macular Degeneration Drug Consumption by Application
4 Global Age Related Macular Degeneration Drug Market Assessment by Regions
4.1 Global Age Related Macular Degeneration Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Age Related Macular Degeneration Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Age Related Macular Degeneration Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Age Related Macular Degeneration Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Age Related Macular Degeneration Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Age Related Macular Degeneration Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Age Related Macular Degeneration Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Age Related Macular Degeneration Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Age Related Macular Degeneration Drug Competitive Analysis
7.1 Applied Genetic Technologies Corp
7.1.1 Applied Genetic Technologies Corp Company Profiles
7.1.2 Applied Genetic Technologies Corp Product Introduction
7.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Astellas Pharma Inc
7.2.1 Astellas Pharma Inc Company Profiles
7.2.2 Astellas Pharma Inc Product Introduction
7.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Benitec Biopharma Ltd
7.3.1 Benitec Biopharma Ltd Company Profiles
7.3.2 Benitec Biopharma Ltd Product Introduction
7.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Biokine Therapeutics Ltd
7.4.1 Biokine Therapeutics Ltd Company Profiles
7.4.2 Biokine Therapeutics Ltd Product Introduction
7.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Crinetics Pharmaceuticals Inc
7.5.1 Crinetics Pharmaceuticals Inc Company Profiles
7.5.2 Crinetics Pharmaceuticals Inc Product Introduction
7.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Critical Pharmaceuticals Ltd
7.6.1 Critical Pharmaceuticals Ltd Company Profiles
7.6.2 Critical Pharmaceuticals Ltd Product Introduction
7.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Daiichi Sankyo Company Ltd
7.7.1 Daiichi Sankyo Company Ltd Company Profiles
7.7.2 Daiichi Sankyo Company Ltd Product Introduction
7.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Diffusion Pharmaceuticals Inc
7.8.1 Diffusion Pharmaceuticals Inc Company Profiles
7.8.2 Diffusion Pharmaceuticals Inc Product Introduction
7.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Dong-A Socio Holdings Co Ltd
7.9.1 Dong-A Socio Holdings Co Ltd Company Profiles
7.9.2 Dong-A Socio Holdings Co Ltd Product Introduction
7.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Eleven Biotherapeutics Inc
7.10.1 Eleven Biotherapeutics Inc Company Profiles
7.10.2 Eleven Biotherapeutics Inc Product Introduction
7.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Elsalys Biotech SAS
7.12 Lupin Ltd
7.13 M's Science Corp
7.14 Mabion SA
7.15 MacuCLEAR Inc
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Age Related Macular Degeneration Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Age Related Macular Degeneration Drug Sales (K Unit) by Type (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Age Related Macular Degeneration Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Age Related Macular Degeneration Drug Sales (K Unit) by Application (2015-2026)
Figure China Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Age Related Macular Degeneration Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Age Related Macular Degeneration Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Age Related Macular Degeneration Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Age Related Macular Degeneration Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Age Related Macular Degeneration Drug Sales (Unit) by Type (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Age Related Macular Degeneration Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Age Related Macular Degeneration Drug Consumption (Unit) by Application (2015-2026)
Figure Global Age Related Macular Degeneration Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Age Related Macular Degeneration Drug Production (K Unite) by Regions (2015-2020)
Table Global Age Related Macular Degeneration Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Age Related Macular Degeneration Drug Production Share by Regions (2019-2020)
Table Global Age Related Macular Degeneration Drug Sales (K Unite) by Regions (2015-2020)
Table Global Age Related Macular Degeneration Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Share by Regions (2019-2020)
Table Global Age Related Macular Degeneration Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Age Related Macular Degeneration Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Age Related Macular Degeneration Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Age Related Macular Degeneration Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Age Related Macular Degeneration Drug
Figure Cost Structure of Age Related Macular Degeneration Drug in 2020
Table Global Age Related Macular Degeneration Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Age Related Macular Degeneration Drug Capacity Share of Manufacturers (2019-2020)
Table Global Age Related Macular Degeneration Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Age Related Macular Degeneration Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Age Related Macular Degeneration Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Age Related Macular Degeneration Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Age Related Macular Degeneration Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Applied Genetic Technologies Corp Profiles
Table ????Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Product Introduction
Table ????Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Applied Genetic Technologies Corp SWOT Analysis
Table ????Astellas Pharma Inc Profiles
Table ????Astellas Pharma Inc Age Related Macular Degeneration Drug Product Introduction
Table ????Astellas Pharma Inc Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Astellas Pharma Inc SWOT Analysis
Table ????Benitec Biopharma Ltd Profiles
Table ????Benitec Biopharma Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Benitec Biopharma Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Benitec Biopharma Ltd SWOT Analysis
Table ????Biokine Therapeutics Ltd Profiles
Table ????Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Biokine Therapeutics Ltd SWOT Analysis
Table ????Crinetics Pharmaceuticals Inc Profiles
Table ????Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Product Introduction
Table ????Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Crinetics Pharmaceuticals Inc SWOT Analysis
Table ????Critical Pharmaceuticals Ltd Profiles
Table ????Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Critical Pharmaceuticals Ltd SWOT Analysis
Table ????Daiichi Sankyo Company Ltd Profiles
Table ????Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Daiichi Sankyo Company Ltd SWOT Analysis
Table ????Diffusion Pharmaceuticals Inc Profiles
Table ????Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Product Introduction
Table ????Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Diffusion Pharmaceuticals Inc SWOT Analysis
Table ????Dong-A Socio Holdings Co Ltd Profiles
Table ????Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dong-A Socio Holdings Co Ltd SWOT Analysis
Table ????Eleven Biotherapeutics Inc Profiles
Table ????Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Product Introduction
Table ????Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eleven Biotherapeutics Inc SWOT Analysis
Table ????Elsalys Biotech SAS Profiles
Table ????Elsalys Biotech SAS Age Related Macular Degeneration Drug Product Introduction
Table ????Elsalys Biotech SAS Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Elsalys Biotech SAS SWOT Analysis
Table ????Lupin Ltd Profiles
Table ????Lupin Ltd Age Related Macular Degeneration Drug Product Introduction
Table ????Lupin Ltd Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Lupin Ltd SWOT Analysis
Table ????M's Science Corp Profiles
Table ????M's Science Corp Age Related Macular Degeneration Drug Product Introduction
Table ????M's Science Corp Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????M's Science Corp SWOT Analysis
Table ????Mabion SA Profiles
Table ????Mabion SA Age Related Macular Degeneration Drug Product Introduction
Table ????Mabion SA Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Mabion SA SWOT Analysis
Table ????MacuCLEAR Inc Profiles
Table ????MacuCLEAR Inc Age Related Macular Degeneration Drug Product Introduction
Table ????MacuCLEAR Inc Age Related Macular Degeneration Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????MacuCLEAR Inc SWOT Analysis